{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:15:17Z","timestamp":1791184517147,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,1,28]],"date-time":"2014-01-28T00:00:00Z","timestamp":1390867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,1,28]],"date-time":"2014-01-28T00:00:00Z","timestamp":1390867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1038\/mp.2013.192","type":"journal-article","created":{"date-parts":[[2014,1,28]],"date-time":"2014-01-28T09:06:42Z","timestamp":1390900002000},"page":"215-223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizers"],"prefix":"10.1038","volume":"20","author":[{"given":"Y","family":"Leng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L-K","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Leeds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E B","family":"Fessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D-M","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,28]]},"reference":[{"key":"BFmp2013192_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","volume":"5","author":"T Inagaki","year":"2007","unstructured":"Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab 2007; 5: 415\u2013425.","journal-title":"Cell Metab"},{"key":"BFmp2013192_CR2","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1210\/en.2009-0221","volume":"150","author":"ED Berglund","year":"2009","unstructured":"Berglund ED, Li CY, Bina HA, Lynes SE, Michael MD, Shanafelt AB et al. Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity. Endocrinology 2009; 150: 4084\u20134093.","journal-title":"Endocrinology"},{"key":"BFmp2013192_CR3","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1210\/en.2008-0816","volume":"149","author":"T Coskun","year":"2008","unstructured":"Coskun T, Bina HA, Schneider MA, Dunbar JD, Hu CC, Chen Y et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 2008; 149: 6018\u20136027.","journal-title":"Endocrinology"},{"key":"BFmp2013192_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0197-0186(93)90143-S","volume":"23","author":"WW Lin","year":"1993","unstructured":"Lin WW, Chuang DM . Agonist-induced desensitization of ATP receptor-mediated phosphoinositide turnover in C6 glioma cells: comparison with the negative-feedback regulation by protein kinase C. Neurochem Int 1993; 23: 53\u201360.","journal-title":"Neurochem Int"},{"key":"BFmp2013192_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2337\/db08-0392","volume":"58","author":"J Xu","year":"2009","unstructured":"Xu J, Lloyd DJ, Hale C, Stanislaus S, Chen M, Sivits G et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 2009; 58: 250\u2013259.","journal-title":"Diabetes"},{"key":"BFmp2013192_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1126\/science.1222646","volume":"336","author":"C Canto","year":"2012","unstructured":"Canto C, Auwerx J . Cell biology. FGF21 takes a fat bite. Science 2012; 336: 675\u2013676.","journal-title":"Science"},{"key":"BFmp2013192_CR7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/BF00966782","volume":"18","author":"WW Lin","year":"1993","unstructured":"Lin WW, Chuang DM . Extracellular ATP stimulates inositol phospholipid turnover and calcium influx in C6 glioma cells. Neurochem Res 1993; 18: 681\u2013687.","journal-title":"Neurochem Res"},{"key":"BFmp2013192_CR8","doi-asserted-by":"publisher","first-page":"10853","DOI":"10.1073\/pnas.0904187106","volume":"106","author":"MJ Potthoff","year":"2009","unstructured":"Potthoff MJ, Inagaki T, Satapati S, Ding X, He T, Goetz R et al. FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc Natl Acad Sci USA 2009; 106: 10853\u201310858.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2013192_CR9","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","volume":"5","author":"MK Badman","year":"2007","unstructured":"Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E . Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 2007; 5: 426\u2013437.","journal-title":"Cell Metab"},{"key":"BFmp2013192_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1124\/mol.108.044826","volume":"74","author":"ES Muise","year":"2008","unstructured":"Muise ES, Azzolina B, Kuo DW, El-Sherbeini M, Tan Y, Yuan X et al. Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states. Mol Pharmacol 2008; 74: 403\u2013412.","journal-title":"Mol Pharmacol"},{"key":"BFmp2013192_CR11","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cell.2011.11.062","volume":"148","author":"PA Dutchak","year":"2012","unstructured":"Dutchak PA, Katafuchi T, Bookout AL, Choi JH, Yu RT, Mangelsdorf DJ et al. Fibroblast growth factor-21 regulates PPARgamma activity and the antidiabetic actions of thiazolidinediones. Cell 2012; 148: 556\u2013567.","journal-title":"Cell"},{"key":"BFmp2013192_CR12","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/0363-5023(92)90451-T","volume":"17","author":"DC Chuang","year":"1992","unstructured":"Chuang DC, Yeh MC, Wei FC . Intercostal nerve transfer of the musculocutaneous nerve in avulsed brachial plexus injuries: evaluation of 66 patients. J Hand Surg Am 1992; 17: 822\u2013828.","journal-title":"J Hand Surg Am"},{"key":"BFmp2013192_CR13","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jhep.2010.05.018","volume":"53","author":"H Li","year":"2010","unstructured":"Li H, Fang Q, Gao F, Fan J, Zhou J, Wang X et al. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. J Hepatol 2010; 53: 934\u2013940.","journal-title":"J Hepatol"},{"key":"BFmp2013192_CR14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0026-895X(25)08942-4","volume":"42","author":"MM Belcheva","year":"1992","unstructured":"Belcheva MM, Barg J, Gloeckner C, Gao XM, Chuang DM, Coscia CJ . Antagonist-induced transient down-regulation of delta-opioid receptors in NG108-15 cells. Mol Pharmacol 1992; 42: 445\u2013452.","journal-title":"Mol Pharmacol"},{"key":"BFmp2013192_CR15","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.2337\/db09-1878","volume":"59","author":"DA Sarruf","year":"2010","unstructured":"Sarruf DA, Thaler JP, Morton GJ, German J, Fischer JD, Ogimoto K et al. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats. Diabetes 2010; 59: 1817\u20131824.","journal-title":"Diabetes"},{"key":"BFmp2013192_CR16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0026-895X(25)08902-3","volume":"42","author":"DM Chuang","year":"1992","unstructured":"Chuang DM, Gao XM, Paul SM . N-methyl-D-aspartate exposure blocks glutamate toxicity in cultured cerebellar granule cells. Mol Pharmacol 1992; 42: 210\u2013216.","journal-title":"Mol Pharmacol"},{"key":"BFmp2013192_CR17","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1210\/en.2011-1496","volume":"153","author":"KR Feingold","year":"2012","unstructured":"Feingold KR, Grunfeld C, Heuer JG, Gupta A, Cramer M, Zhang T et al. FGF21 is increased by inflammatory stimuli and protects leptin-deficient ob\/ob mice from the toxicity of sepsis. Endocrinology 2012; 153: 2689\u20132700.","journal-title":"Endocrinology"},{"key":"BFmp2013192_CR18","doi-asserted-by":"publisher","first-page":"Art. 2019","DOI":"10.1038\/ncomms3019","volume":"4","author":"A Planavila","year":"2013","unstructured":"Planavila A, Redondo I, Hondares E, Vinciguerra M, Munts C, Iglesias R et al. Fibroblast growth factor 21 protects against cardiac hypertrophy in mice. Nat Commun 2013; 4: Art. 2019.","journal-title":"Nat Commun"},{"key":"BFmp2013192_CR19","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1523\/JNEUROSCI.12-03-01077.1992","volume":"12","author":"WW Lin","year":"1992","unstructured":"Lin WW, Kiang JG, Chuang DM . Pharmacological characterization of endothelin-stimulated phosphoinositide breakdown and cytosolic free Ca2+ rise in rat C6 glioma cells. J Neurosci 1992; 12: 1077\u20131085.","journal-title":"J Neurosci"},{"key":"BFmp2013192_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/00006534-199202000-00024","volume":"89","author":"DC Chuang","year":"1992","unstructured":"Chuang DC, Chen HC, Wei FC, Noordhoff MS . Compound functioning free muscle flap transplantation (lateral half of soleus, fibula, and skin flap). Plast Reconstr Surg 1992; 89: 335\u2013339.","journal-title":"Plast Reconstr Surg"},{"key":"BFmp2013192_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1124\/pr.111.005512","volume":"65","author":"CT Chiu","year":"2013","unstructured":"Chiu CT, Wang Z, Hunsberger JG, Chuang DM . Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev 2013; 65: 105\u2013142.","journal-title":"Pharmacol Rev"},{"key":"BFmp2013192_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.pharmthera.2010.07.006","volume":"128","author":"CT Chiu","year":"2010","unstructured":"Chiu CT, Chuang DM . Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther 2010; 128: 281\u2013304.","journal-title":"Pharmacol Ther"},{"key":"BFmp2013192_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0304-3940(91)90725-9","volume":"129","author":"R Li","year":"1991","unstructured":"Li R, Wing LL, Shen Y, Wyatt RJ, Kirch DG, Chuang DM . Chronic haloperidol treatment attenuates receptor-mediated phosphoinositide turnover in rat brain slices. Neurosci Lett 1991; 129: 81\u201385.","journal-title":"Neurosci Lett"},{"key":"BFmp2013192_CR24","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0022-3565(25)24663-8","volume":"257","author":"WW Lin","year":"1991","unstructured":"Lin WW, Lee CY, Chuang DM . Endothelin- and sarafotoxin-induced phosphoinositide hydrolysis in cultured cerebellar granule cells: biochemical and pharmacological characterization. J Pharmacol Exp Ther 1991; 257: 1053\u20131061.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFmp2013192_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","volume":"32","author":"DM Chuang","year":"2009","unstructured":"Chuang DM, Leng Y, Marinova Z, Kim HJ, Chiu CT . Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci 2009; 32: 591\u2013601.","journal-title":"Trends Neurosci"},{"key":"BFmp2013192_CR26","doi-asserted-by":"publisher","first-page":"5105","DOI":"10.2174\/1381612811319280009","volume":"19","author":"EB Fessler","year":"2013","unstructured":"Fessler EB, Chibane FL, Wang Z, Chuang DM . Potential Roles of HDAC Inhibitors in Mitigating Ischemia-induced Brain Damage and Facilitating Endogenous Regeneration and Recovery. Curr Pharm Des 2013; 19: 5105\u20135120.","journal-title":"Curr Pharm Des"},{"key":"BFmp2013192_CR27","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1073\/pnas.95.5.2642","volume":"95","author":"S Nonaka","year":"1998","unstructured":"Nonaka S, Hough CJ, Chuang DM . Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci USA 1998; 95: 2642\u20132647.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2013192_CR28","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1523\/JNEUROSCI.5467-07.2008","volume":"28","author":"Y Leng","year":"2008","unstructured":"Leng Y, Liang MH, Ren M, Marinova Z, Leeds P, Chuang DM . Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition. J Neurosci 2008; 28: 2576\u20132588.","journal-title":"J Neurosci"},{"key":"BFmp2013192_CR29","doi-asserted-by":"publisher","first-page":"7502","DOI":"10.1523\/JNEUROSCI.0096-06.2006","volume":"26","author":"Y Leng","year":"2006","unstructured":"Leng Y, Chuang DM . Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity. J Neurosci 2006; 26: 7502\u20137512.","journal-title":"J Neurosci"},{"key":"BFmp2013192_CR30","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1017\/S1461145710000726","volume":"14","author":"N Omata","year":"2011","unstructured":"Omata N, Chiu CT, Moya PR, Leng Y, Wang Z, Hunsberger JG et al. Lentivirally mediated GSK-3\u03b2 silencing in the hippocampal dentate gyrus induces antidepressant-like effects in stressed mice. Int J Neuropsychopharmacol 2011; 14: 711\u2013717.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFmp2013192_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.tem.2010.11.003","volume":"22","author":"A Kharitonenkov","year":"2011","unstructured":"Kharitonenkov A, Larsen P . FGF21 reloaded: challenges of a rapidly growing field. Trends Endocrinol Metab 2011; 22: 81\u201386.","journal-title":"Trends Endocrinol Metab"},{"key":"BFmp2013192_CR32","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1074\/jbc.M605178200","volume":"282","author":"MH Liang","year":"2007","unstructured":"Liang MH, Chuang DM . Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival. J Biol Chem 2007; 282: 3904\u20133917.","journal-title":"J Biol Chem"},{"key":"BFmp2013192_CR33","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.2337\/db05-1435","volume":"55","author":"W Wente","year":"2006","unstructured":"Wente W, Efanov AM, Brenner M, Kharitonenkov A, Koster A, Sandusky GE et al. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1\/2 and Akt signaling pathways. Diabetes 2006; 55: 2470\u20132478.","journal-title":"Diabetes"},{"key":"BFmp2013192_CR34","doi-asserted-by":"publisher","first-page":"8745","DOI":"10.1073\/pnas.96.15.8745","volume":"96","author":"E Chalecka-Franaszek","year":"1999","unstructured":"Chalecka-Franaszek E, Chuang DM . Lithium activates the serine\/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci USA 1999; 96: 8745\u20138750.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2013192_CR35","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.neuroscience.2008.06.040","volume":"155","author":"HL Feng","year":"2008","unstructured":"Feng HL, Leng Y, Ma CH, Zhang J, Ren M, Chuang DM . Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model. Neuroscience 2008; 155: 567\u2013572.","journal-title":"Neuroscience"},{"key":"BFmp2013192_CR36","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1038\/npp.2011.128","volume":"36","author":"CT Chiu","year":"2011","unstructured":"Chiu CT, Liu G, Leeds P, Chuang DM . Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease. Neuropsychopharmacology 2011; 36: 2406\u20132421.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2013192_CR37","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3171\/2013.6.JNS13135","volume":"119","author":"F Yu","year":"2013","unstructured":"Yu F, Wang Z, Tanaka M, Chiu CT, Leeds P, Zhang Y et al. Posttrauma cotreatment with lithium and valproate: reduction of lesion volume, attenuation of blood-brain barrier disruption, and improvement in motor coordination in mice with traumatic brain injury. J Neurosurg 2013; 119: 766\u2013773.","journal-title":"J Neurosurg"},{"key":"BFmp2013192_CR38","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature10524","volume":"478","author":"C Colantuoni","year":"2011","unstructured":"Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, Leek JT et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011; 478: 519\u2013523.","journal-title":"Nature"},{"key":"BFmp2013192_CR39","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.3249","volume":"19","author":"AL Bookout","year":"2013","unstructured":"Bookout AL, de Groot MH, Owen BM, Lee S, Gautron L, Lawrence HL et al. FGF21 regulates metabolism and circadian behavior by acting on the nervous system. Nat Med 2013; 19: 1147\u20131152.","journal-title":"Nat Med"},{"key":"BFmp2013192_CR40","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/nm.3250","volume":"19","author":"BM Owen","year":"2013","unstructured":"Owen BM, Bookout AL, Ding X, Lin VY, Atkin SD, Gautron L et al. FGF21 contributes to neuroendocrine control of female reproduction. Nat Med 2013; 19: 1153\u20131156.","journal-title":"Nat Med"},{"key":"BFmp2013192_CR41","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.biopsych.2005.10.021","volume":"59","author":"CA Zarate Jr","year":"2006","unstructured":"Zarate CA Jr, Singh J, Manji HK . Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biol Psychiatry 2006; 59: 1006\u20131020.","journal-title":"Biol Psychiatry"},{"key":"BFmp2013192_CR42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1034\/j.1399-5618.2003.00034.x","volume":"5","author":"CA Zarate Jr","year":"2003","unstructured":"Zarate CA Jr, Quiroz JA . Combination treatment in bipolar disorder: a review of controlled trials. Bipolar Disord 2003; 5: 217\u2013225.","journal-title":"Bipolar Disord"},{"key":"BFmp2013192_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00004714-199802000-00007","volume":"18","author":"DA Solomon","year":"1998","unstructured":"Solomon DA, Keitner GI, Ryan CE, Miller IW . Lithium plus valproate as maintenance polypharmacy for patients with bipolar I disorder: a review. J Clin Psychopharmacol 1998; 18: 38\u201349.","journal-title":"J Clin Psychopharmacol"},{"key":"BFmp2013192_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/07853890.2012.687835","volume":"45","author":"CV Calkin","year":"2013","unstructured":"Calkin CV, Gardner DM, Ransom T, Alda M . The relationship between bipolar disorder and type 2 diabetes: more than just co-morbid disorders. Ann Med 2013; 45: 171\u2013181.","journal-title":"Ann Med"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/mp2013192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2013192","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2013192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T17:56:08Z","timestamp":1746122168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2013192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,28]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["BFmp2013192"],"URL":"https:\/\/doi.org\/10.1038\/mp.2013.192","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,28]]},"assertion":[{"value":"31 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}